Bacterial conjunctivitis in children: antibacterial treatment options in an era of increasing drug resistance.
Pichichero
Michael E
ME
Rochester General Hospital, Research Institute Rochester, NY 14621, USA. michael.pichichero@rochestergeneral.org
D000208:Acute Disease; D000617:Aminoglycosides / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D003234:Conjunctivitis, Bacterial / Q000175:diagnosis / Q000188:drug therapy*; D024881:Drug Resistance, Bacterial; D005260:Female; D024841:Fluoroquinolones / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D018942:Macrolides / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D009883:Ophthalmic Solutions / Q000008:administration & dosage; D011112:Polymyxin B / Q000008:administration & dosage / Q000627:therapeutic use; D017410:Practice Guidelines as Topic
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D024841:Fluoroquinolones; D018942:Macrolides; D009883:Ophthalmic Solutions; D011112:Polymyxin B